Site icon Healthcare, Lifestyle, Entertainment, Living and Travel

FDA sets target action date for Rhythm’s sNDA for Imcivree (NASDAQ:RYTM)


To guarantee this doesn’t occur sooner or later, please allow Javascript and cookies in your browser.

Is this taking place to you incessantly? Please report it on our suggestions discussion board.

If you could have an ad-blocker enabled you could be blocked from continuing. Please disable your ad-blocker and refresh.



Source: Seekingalpha

Exit mobile version